Observational studyBreast (Edinburgh, Scotland)2026

Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study.

Francesca Ligorio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.